What is the safest method to cross‑taper a patient from fluoxetine 40 mg daily to nortriptyline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cross-Tapering from Fluoxetine to Nortriptyline

Due to fluoxetine's exceptionally long half-life (4-6 days for fluoxetine, 4-16 days for its active metabolite norfluoxetine), you should discontinue fluoxetine 40 mg and wait a minimum of 5 weeks before initiating nortriptyline to avoid serotonin syndrome and dangerous drug interactions. 1

Critical Safety Considerations

Why a Washout Period is Essential

Fluoxetine is a potent CYP2D6 inhibitor that will dramatically increase nortriptyline levels if co-administered. 1 The FDA drug label explicitly warns that fluoxetine inhibits CYP2D6 and can make normal metabolizers resemble poor metabolizers. Since nortriptyline is metabolized by CYP2D6, combining these medications risks:

  • Severe cardiotoxicity (nortriptyline has narrow therapeutic index)
  • Anticholinergic toxicity
  • Serotonin syndrome from combining two serotonergic agents 2

The guideline evidence emphasizes that caution must be exercised when combining serotonergic drugs (SSRIs and TCAs), with particular attention to starting the second drug at low doses and monitoring closely in the first 24-48 hours 2. However, this conservative cross-taper approach is NOT safe with fluoxetine due to its unique pharmacokinetics.

The 5-Week Washout Requirement

The FDA label states that if fluoxetine is discontinued, clinicians must wait "a minimum of 5 weeks" before starting medications metabolized by CYP2D6 with narrow therapeutic indices 1. This washout period accounts for:

  • Fluoxetine's very long half-life requiring weeks to clear 3
  • Continued CYP2D6 inhibition during this entire period
  • Nortriptyline's narrow therapeutic window (50-150 ng/mL) 3

Recommended Switching Protocol

Step 1: Discontinue Fluoxetine (Week 0)

  • Stop fluoxetine 40 mg abruptly
  • Fluoxetine does NOT require gradual tapering due to its long half-life providing a "self-tapering" effect 1, 4
  • Discontinuation syndrome is uncommon with fluoxetine compared to shorter-acting SSRIs 2

Step 2: Washout Period (Weeks 1-5)

  • Monitor for:
    • Worsening depression symptoms
    • Anxiety, agitation, or mood destabilization
    • Any emergence of suicidal ideation 1
  • Provide supportive care and close follow-up
  • Consider temporary symptomatic management if needed (avoid other serotonergic agents)

Step 3: Initiate Nortriptyline (Week 6 onwards)

After the full 5-week washout:

  • Start nortriptyline 10 mg at bedtime 3
  • Increase by 10-25 mg every 3-7 days as tolerated 5, 6
  • Target therapeutic dose: 40-100 mg/day (given once daily or divided twice daily) 3
  • Monitor for:
    • Anticholinergic effects (dry mouth, urinary retention, constipation)
    • Orthostatic hypotension
    • Cardiac conduction changes (obtain baseline ECG if indicated)
    • Therapeutic blood levels (target 50-150 ng/mL) 3

Dose Equivalency Context

Based on randomized controlled trial data, fluoxetine 40 mg is approximately equivalent to nortriptyline 100.9 mg 7. This suggests your target nortriptyline dose should be in the 75-125 mg range for equivalent antidepressant effect, though individual titration based on response and tolerability is necessary.

Common Pitfalls to Avoid

  1. Never attempt a direct cross-taper - The combination risks life-threatening toxicity
  2. Do not shorten the washout period - Even 3-4 weeks may be insufficient given individual pharmacokinetic variability
  3. Do not use alternate-day dosing strategies - This increases withdrawal risk and is not applicable to fluoxetine anyway 8
  4. Monitor closely during washout - The gap in antidepressant coverage may precipitate relapse requiring intervention

Alternative Consideration

If the 5-week medication-free period poses unacceptable clinical risk due to severe depression, consider switching to a different antidepressant that doesn't require such an extended washout (e.g., an SNRI or different SSRI), rather than proceeding with nortriptyline. The safety imperative of avoiding fluoxetine-nortriptyline interaction outweighs the inconvenience of the washout period.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.